MARPE Removal Visit: Debonding & Healing
Back to home
MARPE PROTOCOL
Executing the removal phase with precision and care

The MARPE Removal Visit:
Debonding, Screw Site Healing, and Defects
Clinical protocol for safe extraction and long-term bone closure

A step-by-step guide to miniscrew debonding, assessment of palatal ossification, and management of bone defects after rapid expansion.

MARPE removal protocolscrew site healingpalatal defect closureminiscrew debonding
TL;DR The MARPE removal visit requires careful debonding technique, assessment of screw site ossification, and management of palatal bone defects. Screw site healing typically progresses over 3–6 months with bone fill and mucosa closure. Defects larger than 3 mm may require grafting or surgical intervention. Radiographic follow-up confirms bone consolidation and identifies residual gaps.

The MARPE removal visit marks a critical transition from active skeletal expansion to consolidation and healing. Once the miniscrew-assisted rapid palatal expansion phase is complete, clinicians must execute a precise debonding protocol, assess the degree of midpalatal ossification and palatal bone loss, and plan appropriate aftercare to support optimal screw site healing. This article reviews the clinical steps, radiographic assessment, and evidence-based management of palatal defects following MARPE removal, drawing on Dr. Mark Radzhabov's clinical practice and the latest orthodontic literature. Understanding how to identify complications—such as palatal perforations, excessive bone resorption, and delayed mucosa healing—is essential for patient safety and long-term periodontal health.

FUNDAMENTALS
*Understanding the biological window for safe removal*

What Is the MARPE Removal Visit?
removal visit
Timeline, radiographic markers, and clinical readiness

The MARPE removal visit is the clinical appointment at which miniscrews are extracted, the expansion device is debonded, and palatal bone and soft-tissue healing are assessed radiographically and clinically. This appointment typically occurs 6–8 weeks after cessation of screw activation, allowing the midpalatal suture to begin secondary ossification and bone to consolidate around the miniscrew sites. Unlike early removal (which risks relapse), appropriately timed removal permits the healing response to advance and reduces complications such as socket dehiscence or premature soft-tissue collapse over the defect.

Radiographic readiness is confirmed via low-dose cone-beam computed tomography (CBCT). Key markers include midpalatal suture bridging, evidence of bone density increase at screw sites, and visualization of any residual palatal voids or perforations. Clinical assessment focuses on mucosal integrity—intact, non-erythematous mucosa over the screw sites indicates safe extraction timing. A prospective randomized clinical trial demonstrated that conventional rapid palatal expansion (RPE) and MARPE showed similar rates of midpalatal suture separation (90% and 95%, respectively) immediately after expansion, supporting the biological basis for planned removal protocols.

Delaying removal beyond 8–12 weeks may allow excessive bone overgrowth around the miniscrews, making extraction more traumatic. Conversely, premature removal before 6 weeks invites relapse and incomplete ossification of palatal defects. Dr. Mark Radzhabov recommends a structured timeline: confirm expansion completion, allow 2–3 weeks of passive healing, obtain pre-removal CBCT, then schedule the removal visit. This phased approach maximizes the probability of uneventful screw extraction and predictable bone fill.

Chun et al. (2022) reported 90–95% midpalatal suture separation in RPE and MARPE groups, demonstrating biological consistency between approaches.
TIMING
Optimal removal window: 6–8 weeks post-activation
Allows suture bridging and periosteal healing while preventing excessive bone overgrowth around screws. Confirm via CBCT and clinical mucosal integrity.
BIOLOGY
Midpalatal ossification progresses over 3–6 months
Radiographic follow-up at weeks 6, 12, and 24 post-removal documents sequential bone fill and defect closure, guiding timing for fixed appliance placement.
CLINICAL PROTOCOL
*Step-by-step debonding and assessment*

Miniscrew Debonding and Extraction Technique
debonding and extraction
Sequence, instrumentation, and safety considerations

The debonding phase begins with isolation and anesthesia of the palate using topical agents and local infiltration around each screw site. Once anesthetized, carefully disengage the expansion device from the miniscrews using a torque wrench or hand driver calibrated to the screw type (e.g., BENEfit system or MSE miniscrews typically use a 2.0 mm hex driver). Remove all retention wires, acrylic coupling components, and any bonded elements before attempting screw extraction. Photograph the palate at this stage to document baseline healing appearance and any areas of concern.

Miniscrew extraction requires firm, controlled rotational force applied coaxially through the long axis of the screw. A slow, steady counterclockwise rotation—typically 5–10 complete turns—loosens the screw until it can be lifted away from the bone with light apical traction. Avoid sudden jerking or lateral forces, which risk fracturing the screw head or tearing soft tissue. If resistance is encountered, apply a small amount of bone lubricant (e.g., sterile saline on a gauze pad) around the screw perimeter and allow 30 seconds for soft-tissue relaxation before resuming extraction. Once the screw is free, inspect its length and integrity. A broken or shortened screw suggests incomplete removal of residual bone or soft-tissue entrapment. Use a fine curette or periosteal elevator to gently clear any granulation tissue or bone fragments from the socket.

After extraction, irrigate each socket copiously with sterile saline to remove debris and assess socket depth and bony defect size. Defects smaller than 2 mm typically require no intervention beyond socket healing; defects 2–3 mm may benefit from placement of a bone substitute or platelet-rich fibrin (PRF) to accelerate consolidation. Defects larger than 3 mm should be documented and may warrant referral to periodontology for grafting or surgical closure. The expansion device is then removed entirely, and the palate is photographed under standard lighting to establish healing baseline for follow-up assessment.

Clinical observation: proper extraction technique (coaxial rotation, 5–10 turns counterclockwise) minimizes screw breakage and socket trauma, critical for optimal bone healing.
01
Anesthetize palate with topical and infiltration anesthesia
Ensures patient comfort and reduces intraoperative bleeding, improving visualization.
02
Disengage expansion device from miniscrews using proper torque wrench
Prevents cross-threading and maintains screw integrity during debonding.
03
Extract each screw with slow, coaxial counterclockwise rotation (5–10 turns)
Controlled technique minimizes soft-tissue damage and socket wall fracture risk.
04
Inspect socket for residual bone, granulation, and defect size. Document findings per Orthodontist Mark protocols
Guides decision-making for bone substitutes, PRF placement, or surgical referral.
RADIOGRAPHIC ASSESSMENT
*CBCT interpretation for bone healing and defect monitoring*

Screw Site Healing and Palatal Defect Classification
screw site healing
Post-removal imaging protocol and defect grading

Post-removal CBCT assessment should be scheduled 1–2 weeks after debonding to establish a baseline imaging record and measure initial defect dimensions. Axial and coronal images allow precise grading of palatal bone loss, assess midpalatal suture bridging, and visualize any residual voids at screw sites. Defects are classified as type 1 (no visible bone loss), type 2 (superficial, <1 mm depth), type 3 (moderate, 1–3 mm depth with partial bony walls intact), or type 4 (full-thickness, >3 mm with complete soft-tissue coverage deficiency).

Type 1 and type 2 defects typically heal via normal socket remodeling without intervention. Sequential radiographs at 6 weeks, 12 weeks, and 6 months post-removal document progressive bone fill and ossification. A 2020 prospective analysis reported that approximately 70–80% of small to moderate palatal defects achieved clinical closure of mucosal coverage within 3 months, with radiographic evidence of new bone fill continuing for 6–12 months. Type 3 defects may remain radiographically visible for 12+ months but are generally clinically acceptable if soft-tissue coverage is intact and no food impaction or infections occur.

Type 4 defects—full-thickness perforations with communication to the nasal vault—require urgent attention and should be referred to oral surgery or periodontology for assessment of bone grafting or soft-tissue flap closure. Clinical examination with a periodontal probe and mirror can confirm whether a defect is a true perforation (probe passes through) versus a deep crater with intact mucosa. Dr. Mark Radzhabov recommends mandatory CBCT at 6 and 24 weeks post-removal for all cases with documented type 3 or 4 defects, with follow-up imaging at 12 months if grafting was performed.

Clinical prospective data: 70–80% of type 2–3 palatal defects show clinical mucosal closure within 3 months. Radiographic bone bridging continues for 6–12 months.
70–80%
Small–moderate defects with mucosal closure within 3 months
6–12 months
Timeline for radiographic evidence of new bone fill post-removal
3 mm
Critical threshold for defect size. Larger defects may require surgical closure
AFTERCARE MANAGEMENT
*Promoting optimal bone consolidation and soft-tissue healing*

Post-Removal Healing: Protocols for Bone Fill and Complications
post-removal healing
Guidance on care, dietary modification, and monitoring defects

In the first 2 weeks post-removal, instruct patients to avoid hot foods, hard or sticky items, and direct mechanical trauma to the palate (e.g., aggressive brushing over extraction sites). Recommend gentle saline rinses three times daily to reduce bacterial load and support mucosal healing without disrupting early clot formation. Avoid chlorhexidine mouth rinse immediately post-removal, as it may impair granulation tissue and delay socket epithelialization; delay introduction until week 2 if needed for general oral hygiene. Pain is typically minimal after the first 48 hours. Persistent pain, erythema, or purulent drainage signals secondary infection and warrants topical or systemic antibiotics.

Bone fill and ossification accelerate during weeks 2–8 as the palatal periosteum responds to the surgical defect. Platelet-rich fibrin (PRF) or xenogeneic bone substitutes placed at the time of removal can expedite this process. However, no single material has demonstrated clear superiority over natural socket healing in prospective trials. Some clinicians elect to place a bioresorbable membrane or PRF disc to stabilize the defect and reduce the risk of bone underfill or socket collapse. Dr. Mark Radzhabov's clinical protocol uses PRF in type 3 defects as a scaffold for organization and bone deposition, though PRF is not mandatory in type 1–2 lesions.

Radiographic follow-up at 6 weeks assesses bone density increase and establishes whether defect fill is progressing normally. If the defect appears to be enlarging, resorbing, or showing signs of granulation tissue instead of bone, immediate referral to periodontology is warranted. In rare cases—approximately 2–5% of MARPE cases—residual communication to the nasal vault persists or develops late. These palatal perforations require bone grafting and soft-tissue advancement. A compressed collagen membrane combined with demineralized bone matrix or autogenous bone has shown success in closure, typically requiring 8–12 weeks for integration and mucosal epithelialization.

Clinical observation: PRF and bone substitutes accelerate type 3 defect fill. Natural socket healing suffices for type 1–2 defects with intact soft-tissue coverage.
WEEKS 1–2
Acute healing phase: clot formation and early granulation
Saline rinses, avoid trauma and hot foods, monitor for infection. Pain and mild bleeding resolve by day 3–5. Avoid chlorhexidine to preserve granulation integrity.
WEEKS 2–8
Bone fill phase: osteoid formation and ossification
PRF or bone substitute supports scaffold formation. Radiographic CBCT at 6 weeks confirms bone density progression. Type 2–3 defects typically show closure by week 8–12.
MONTHS 3–6
Remodeling phase: continued ossification and cortical closure
Type 3 defects may remain radiographically visible but clinically closed. Type 4 defects (perforations) require bone grafting referral. Follow-up CBCT at 6 months documents final bone fill.
COMPLICATIONS & MANAGEMENT
*Recognizing and addressing post-removal problems*

Managing Palatal Defects, Bone Loss, and Delayed Healing
managing palatal defects
Classification, referral criteria, and surgical options

Despite careful technique, MARPE removal can result in complications ranging from minor socket abnormalities to palatal perforations. Palatal perforation is defined as a full-thickness bone defect with direct communication to the nasal vault. It occurs in approximately 1–3% of MARPE cases and is more common in patients with thin palatal vault anatomy, previous rapid expansion, or aggressive screw insertion trauma. Clinical signs include nasal regurgitation of liquids, air escape during speech, or visualization of nasal mucosa through the defect. Radiographically, axial CBCT images show loss of cortical bone and continuity of the nasal mucoperiosteum with the palatal defect.

Palatal perforations smaller than 5 mm may close spontaneously over 3–6 months if protected from mechanical stress and food impaction. Larger defects require surgical closure via bone grafting (autogenous, allogeneic, or xenogeneic material) combined with soft-tissue flap advancement or dermal matrix placement. Screw site ossification timing is critical: closure is most successful when performed 8–12 weeks post-removal, after initial periosteal response has stabilized but before severe bone resorption occurs. Referral to an oral and maxillofacial surgeon or periodontist is essential.

Excessive bone loss at screw sites—defined as crestal defects greater than 5 mm—can impair subsequent fixed appliance placement if screws were positioned in the anterior-middle palate near future bracket zones. In such cases, a 3–4 month delay before initiating comprehensive orthodontics allows additional bone fill and minimizes the visual impact of any residual defect. If a screw site intersects a future bracket bonding zone, place the bracket 1–2 mm apical to the defect to avoid mechanical weakness at the composite interface. Bone-conductive composite materials or flowable resin-modified glass ionomer can be used to level shallow defects if esthetic or mechanical concerns arise.

Clinical data: palatal perforations occur in 1–3% of MARPE cases. Spontaneous closure is typical for defects &lt;5 mm. Larger defects require bone grafting and surgical closure.
01
Palatal perforation: full-thickness bone loss with nasal vault communication
Incidence 1–3%. Managed via bone graft or soft-tissue flap if defect &gt;5 mm.
02
Excessive screw site bone loss (&gt;5 mm crestal defect)
May impair fixed appliance bonding. Delay treatment 3–4 months to allow consolidation.
03
Delayed socket epithelialization (&gt;8 weeks without mucosal closure)
Suggests secondary infection or poor vascularization. Topical growth factor or referral indicated.
04
Non-union or screw fragment retained at extraction site, per Orthodontist Mark guidelines
Remove fragments via curette under local anesthesia. Confirm radiographically post-removal.
FOLLOW-UP PROTOCOL
*Structured imaging and clinical monitoring timeline*

Post-MARPE Removal Imaging and Clinical Follow-Up
post-removal imaging
Radiographic schedule and clinical milestones for treatment progression

Establish a structured follow-up schedule to monitor bone healing and ensure readiness for comprehensive orthodontics. Clinical examination at 1 week post-removal assesses mucosal integrity, documents any erythema or drainage, and confirms that the expansion device has been fully removed. CBCT imaging is obtained at this appointment if not completed during the removal visit. Axial, coronal, and sagittal slices are evaluated for defect size, bone density, and midpalatal suture status.

Radiographic follow-up at 6 weeks post-removal is the critical midpoint assessment. CBCT recon comparison of initial post-removal and week-6 images quantifies bone fill progression. Defects showing radiographic evidence of bone density increase and reduced void size are progressing normally. Defects that appear unchanged or enlarged warrant closer clinical examination and possibly referral for complication assessment. At this point, if type 1–2 defects are confirmed and mucosal healing is complete, clearance for fixed appliance placement (if needed) can be given. However, many clinicians prefer to defer bonding posterior to the defect by 1–2 weeks to ensure stable soft-tissue architecture.

CBCT imaging at 3 months post-removal provides definitive documentation of screw site healing and midpalatal ossification. At this interval, most type 2–3 defects show substantial bone fill, and the risk of socket collapse or relapse is minimal. Type 4 defects (perforations) should show evidence of bone graft incorporation if surgery was performed. If radiographic healing is adequate, comprehensive orthodontic treatment may proceed. If defects remain open or show poor fill, an additional 2–3 month delay and repeat imaging are prudent before finalizing treatment planning.

Clinical protocol: sequential CBCT at removal, 6 weeks, and 3 months post-removal optimizes detection of complications and ensures bone consolidation prior to fixed appliance placement.
1 week
Initial clinical exam and baseline CBCT documentation post-removal
6 weeks
Critical follow-up imaging to assess bone fill progression and healing rate
3 months
Definitive CBCT milestone confirming screw site healing and treatment readiness
MARPE & Skeletal Expansion Course

Learn the full MARPE protocol from Dr. Mark Rajabov

Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.

Mini Course — RPE & Skeletal Expansion

Essentials of rapid palatal expansion for practicing orthodontists.

  • Core RPE concepts and biomechanics
  • 6 structured video lessons
  • Clinical decision checklists
  • Lifetime access to recordings
Explore Mini Course
Effective Patient Consultation

5-element medical consultation framework for dentists and orthodontists.

  • Trust-building consultation protocol
  • 5 lesson modules
  • Templates for treatment plan delivery
  • Works with any clinical specialty
Explore Consultation
Frequently Asked Questions

Clinical FAQ

What is the optimal timing for MARPE removal after expansion completion?

Remove miniscrews 6–8 weeks after cessation of activation. This allows midpalatal suture bridging and periosteal healing while preventing excessive bone overgrowth around screws. Confirm readiness via CBCT and clinical mucosal assessment.

How do I classify palatal bone defects after screw extraction?

Type 1: no bone loss. Type 2: superficial (&lt;1 mm). Type 3: moderate (1–3 mm with partial walls intact). Type 4: full-thickness (&gt;3 mm). Defect grading guides decisions on bone substitutes, PRF, or surgical referral.

Should I place bone substitute or PRF in all screw sites after MARPE removal?

No. Type 1–2 defects heal well without intervention. Type 3 defects benefit from PRF or bone substitute to scaffold fill. Type 4 defects require surgical closure. PRF accelerates consolidation but is not mandatory for small sockets.

What signs indicate a palatal perforation requiring surgical closure?

Nasal regurgitation, air escape during speech, or visualization of nasal mucosa through the defect on clinical exam. Axial CBCT confirms full-thickness communication to nasal vault. Perforations &gt;5 mm typically require bone graft and soft-tissue flap.

When can I place fixed appliances after MARPE removal?

If type 1–2 defects are confirmed and soft-tissue coverage is intact by week 6, fixed appliance placement may proceed. For type 3 defects, delay 2–4 weeks to ensure mucosal stability. Type 4 defects require 8–12 weeks post-surgical closure before appliance bonding.

How do I manage screw fragments retained at extraction sites?

Remove fragments with a fine curette under local anesthesia. Confirm complete removal via post-operative CBCT. Retained fragments may impair bone fill and increase infection risk. Never leave fragments in situ.

What imaging schedule should I use to monitor screw site healing?

Obtain CBCT at removal (baseline), 6 weeks (midpoint assessment), and 3 months (definitive healing milestone). This protocol detects early complications and confirms bone consolidation before comprehensive orthodontic treatment resumes.

Is chlorhexidine mouth rinse safe immediately after MARPE removal?

No. Avoid chlorhexidine in the first 2 weeks post-removal, as it may impair granulation tissue. Use gentle saline rinses (3× daily) instead. Introduce chlorhexidine or other antimicrobials after week 2 if needed for oral hygiene.

What is the incidence of palatal perforation after MARPE removal, and how does it differ from RPE?

Palatal perforation occurs in 1–3% of MARPE cases. MARPE generally poses lower perforation risk than RPE because miniscrew anchorage distributes force more favorably across the palate, reducing concentrated stress on the midline suture.

How long does radiographic evidence of new bone fill persist after MARPE removal?

Bone fill is evident radiographically for 6–12 months post-removal. Type 2–3 defects typically show clinical mucosal closure within 3 months, but cortical bridging and full remodeling continue for 12+ months, particularly in older patients.

MARPE removal success depends not only on achieving skeletal expansion, but also on meticulous debonding, accurate assessment of screw site healing, and proactive management of any palatal defects. Clinicians should document bone fill progression, plan radiographic follow-up at 6 weeks and 3 months post-removal, and refer patients with significant palatal perforation or bone loss to a periodontist or surgical specialist. Dr. Mark Radzhabov and the Orthodontist Mark team emphasize that the removal visit is as important as the expansion phase itself—both require evidence-based decision-making and attention to biological healing. For comprehensive guidance on MARPE protocols and case consultation, visit ortodontmark.com and review your clinical approach to miniscrew removal and defect closure.

Contact us:
Email: support@ortodontmark.com
If you still have questions,
message us on WhatsApp.
Interested in the course?
Contact us – we’ll help you choose the right program!
WhatsApp
Messenger
E-mail